GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » Forward Dividend Yield %

Assembly Biosciences (FRA:V7B) Forward Dividend Yield % : 0.00% (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences Forward Dividend Yield %?

As of today (2024-09-22), the Forward Annual Dividend Yield of Assembly Biosciences is 0.00%.

As of today (2024-09-22), the Trailing Annual Dividend Yield of Assembly Biosciences is 0.00%.

FRA:V7B's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59
* Ranked among companies with meaningful Forward Dividend Yield % only.

Assembly Biosciences's Dividends per Share for the three months ended in Jun. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Assembly Biosciences's Forward Dividend Yield %

For the Biotechnology subindustry, Assembly Biosciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assembly Biosciences's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's Forward Dividend Yield % falls into.



Assembly Biosciences Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Assembly Biosciences  (FRA:V7B) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Assembly Biosciences Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Assembly Biosciences Business Description

Traded in Other Exchanges
Address
331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.

Assembly Biosciences Headlines

No Headlines